Back

Defibrillator capability and all-cause mortality in patients receiving cardiac resynchronization therapy for non-ischemic cardiomyopathy: a Korean nationwide cohort study

16 April 2023 (11:19 - 11:27)
Organised by:
Congress Presentation Part of: Devices - Round 1 - CRT, CSP Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2023

About the speaker

Photo
Associate Professor Pil-Sung Yang

CHA University, Seongnam (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Predictive value of scar burden assessed by cardiac MRI on sudden cardiac death in cardiac resynchronization therapy patients: a systematic review and meta-analysis
Doctor R. Masszi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Dyssynchrony assessment by ultra-high-frequency electrocardiography: a single numerical parameter to identify the relationship between right and left ventricular depolarization
Doctor P. Jurak (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Repolarization changes following conduction system pacing evaluated by ultra-high-frequency electrocardiography
Ms U. Nguyen (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Combination of current and new electrocardiographic-based criteria: a novel score for the discrimination of left bundle branch capture
Doctor A. Estevez Paniagua (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Predictors of the efficacy of AV-optimised His bundle pacing in patients with a prolonged PR interval: a stratified analysis of the HOPE-HF clinical trial
Doctor D. Keene (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Devices - Round 1 - CRT, CSP
Video

The Event

Event poster

EHRA 2023

16 April 2023 11:19 CET
You may be interested in
thumbnail
Congress Presentation
CRT-P vs CRT-D in non-ischemic cardiomyopathy: still a matter of debate
thumbnail
Congress Session
Cardiac resynchronisation and implantable cardioverter-defibrillator therapy
thumbnail
Congress Presentation
Cardiac resynchronisation therapy: the role of the defibrillator

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources